delavirdine has been researched along with histidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzarini, J; De Clercq, E; Dunkler, A; Esnouf, R; Karlsson, A; Kleim, JP; Parniak, MA; Pelemans, H; Vandamme, AM | 1 |
| Balzarini, J; De Clercq, E; Esnouf, RM; Parniak, MA; Pelemans, H; Vandamme, AM | 1 |
2 other study(ies) available for delavirdine and histidine
| Article | Year |
|---|---|
Characteristics of the Pro225His mutation in human immunodeficiency virus type 1 (HIV-1) reverse transcriptase that appears under selective pressure of dose-escalating quinoxaline treatment of HIV-1.
Topics: Amino Acid Substitution; Anti-HIV Agents; Binding Sites; Delavirdine; Drug Resistance, Microbial; Histidine; HIV Reverse Transcriptase; Kinetics; Ligands; Point Mutation; Proline; Quinoxalines; Reverse Transcriptase Inhibitors; Time Factors | 1997 |
A proline-to-histidine substitution at position 225 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) sensitizes HIV-1 RT to BHAP U-90152.
Topics: Amino Acid Substitution; Anti-HIV Agents; Delavirdine; Histidine; HIV Reverse Transcriptase; HIV-1; Humans; Proline; Reverse Transcriptase Inhibitors | 1998 |